Adams Helen C. 4
4 · Immix Biopharma, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Adams Helen C.
Director
Transactions
- Award
Common Stock
2024-05-20+74,241→ 174,754 total - Award
Common Stock
2024-05-15+87,740→ 100,740 total
Footnotes (3)
- [F1]Issued to replace prior awards held by the Reporting Person in Nexcella, Inc., in contemplation of the merger of Nexcella, Inc. and the Issuer, which became effective on May 20, 2024.
- [F2]Restricted Stock Awards which will vest in thirteen (13) equal monthly installments following the date of grant, subject to the Reporting Person's continued service with the Issuer.
- [F3]Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity.